Overall, we discovered a novel regulatory pathway, MUC1/ERK/ITGA2/3, in cervical squamous cell carcinoma that may serve as a potential biomarker and therapeutic target in the future. This evidence concerns the gene ITGA2 and cervical squamous cell carcinoma.